Online inquiry

IVTScrip™ mRNA-Human ARHGAP25, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26790MR)

This product GTTS-WK26790MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP25 protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001007231.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9938
UniProt ID P42331
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP25, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26790MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26878MR IVTScrip™ mRNA-Human ARRDC1-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARRDC1-AS1
GTTS-WK9615MR IVTScrip™ mRNA-Human AAMDC, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AAMDC
GTTS-WK21212MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK19569MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AKIRIN1
GTTS-WK25677MR IVTScrip™ mRNA-Human ARRDC1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARRDC1
GTTS-WK22000MR IVTScrip™ mRNA-Human ARHGAP45, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP45
GTTS-WK22599MR IVTScrip™ mRNA-Human ARHGAP4, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP4
GTTS-WK18016MR IVTScrip™ mRNA-Human AGT, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AGT
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW